control group:placebo
Sponsors
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shanghai Tenth People's Hospital, Department of Neurology, Beijing Hospital, The 925th Hospital, Jiangyin People's Hospital
Conditions
Radiation Xwrostomiaprimary dysmenorrheasarcopeniathyroid carcinomavascular cognitive impairment non-dementia
Early Phase 1
A prospective randomized controlled clinical trial on the efficacy of Omega-3 regulating intestinal microecology in the treatment of thyroid carcinoma after 131I ablation
RecruitingChiCTR2000037157
Start: 2020-10-01Updated: 2020-10-05
Clinical study on the intervention of Shen Weisheng's traditional Chinese Medicine Qingre Lianyin Decoction on the side effects of radiotherapy on head and neck tumors
RecruitingITMCTR2100004593
Start: 2021-01-01Updated: 2023-02-20
A multicenter, randomized, double-blind placebo-controlled, pretrial clinical study for the effect of Yang-Xue Qing-Nao pill in the treatment of vascular cognitive impairment non-dementia (VCIND)
RecruitingChiCTR2100046995
Start: 2021-05-31Updated: 2022-01-18
A multicenter, randomized, double-blind placebo-controlled, pretrial clinical study for the effect of Yang-Xue Qing-Nao pill in the treatment of vascular cognitive impairment non-dementia (VCIND)
RecruitingITMCTR2100004911
Start: 2021-05-31Updated: 2023-02-20
Phase 4
Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients with Qi-Stagnation and Blood-Stasis pattern (CheruPDYS): a randomized placebo controlled trial
RecruitingITMCTR1900002703
Start: 2019-11-01Updated: 2023-02-20
Chinese herbal formula Xuefu Zhuyu for primary dysmenorrhea patients with Qi-Stagnation and Blood-Stasis pattern (CheruPDYS): a randomized placebo controlled trial and an observational study
RecruitingChiCTR1900026819
Start: 2019-11-01Updated: 2021-09-20